Agios Pharmaceuticals price target cut to $37 by Truist
Truist Securities cut its Agios Pharmaceuticals price target to $37.00 from $39.00 and maintained a Buy rating, per Benzinga.
Story updates
03:22:06 PM UTC
SquawkNews
Agios Pharmaceuticals Price Target Cut to $37.00/Share From $39.00 by Truist Securities
03:22:22 PM UTC
SquawkNews
Agios Pharmaceuticals Is Maintained at Buy by Truist Securities